1	Wolinella	Wolinella	B-NP	NNP	O	2	NMOD
2	recta	recta	I-NP	NN	O	0	ROOT
3	in	in	B-PP	IN	O	2	NMOD
4	adult	adult	B-NP	JJ	O	7	NMOD
5	gingivitis	gingivitis	I-NP	NN	O	7	NMOD
6	and	and	I-NP	CC	O	7	NMOD
7	periodontitis	periodontitis	I-NP	NN	O	3	PMOD
8	.	.	O	.	O	2	P

1	Wolinella	Wolinella	B-NP	NN	O	2	NMOD
2	recta	recta	I-NP	NN	O	3	SUB
3	has	have	B-VP	VBZ	O	16	VMOD
4	been	be	I-VP	VBN	O	3	VC
5	associated	associate	I-VP	VBN	O	4	VC
6	with	with	B-PP	IN	O	5	VMOD
7	adult	adult	B-NP	JJ	O	8	NMOD
8	periodontitis	periodontitis	I-NP	NN	O	6	PMOD
9	,	,	O	,	O	16	P
10	but	but	O	CC	O	16	VMOD
11	its	its	B-NP	PRP$	O	12	NMOD
12	role	role	I-NP	NN	O	16	SUB
13	in	in	B-PP	IN	O	12	NMOD
14	the	the	B-NP	DT	O	15	NMOD
15	disease	disease	I-NP	NN	O	13	PMOD
16	remains	remain	B-VP	VBZ	O	0	ROOT
17	uncertain	uncertain	B-ADJP	JJ	O	16	PRD
18	.	.	O	.	O	16	P

1	This	This	B-NP	DT	O	2	NMOD
2	report	report	I-NP	NN	O	3	SUB
3	clarifies	clarify	B-VP	VBZ	O	0	ROOT
4	the	the	B-NP	DT	O	5	NMOD
5	distribution	distribution	I-NP	NN	O	3	OBJ
6	of	of	B-PP	IN	O	5	NMOD
7	W.	W.	B-NP	NNP	O	8	NMOD
8	recta	recta	I-NP	NN	O	6	PMOD
9	in	in	B-PP	IN	O	5	NMOD
10	periodontally	periodontally	B-NP	RB	O	11	AMOD
11	healthy	healthy	I-NP	JJ	O	13	AMOD
12	and	and	I-NP	CC	O	13	AMOD
13	diseased	diseased	I-NP	JJ	O	14	NMOD
14	subjects	subject	I-NP	NNS	O	9	PMOD
15	,	,	O	,	O	18	P
16	and	and	O	CC	O	18	NMOD
17	treated	treat	B-VP	VBN	O	18	NMOD
18	patients	patient	B-NP	NNS	O	3	VMOD
19	with	with	B-PP	IN	O	18	NMOD
20	recurrent	recurrent	B-NP	JJ	O	21	NMOD
21	disease	disease	I-NP	NN	O	19	PMOD
22	.	.	O	.	O	3	P

1	A	A	B-NP	DT	O	5	NMOD
2	specific	specific	I-NP	JJ	O	5	NMOD
3	polyclonal	polyclonal	I-NP	JJ	O	5	NMOD
4	rabbit	rabbit	I-NP	NN	O	5	NMOD
5	antiserum	antiserum	I-NP	NN	O	11	SUB
6	against	against	B-PP	IN	O	5	NMOD
7	W.	W.	B-NP	NNP	O	9	NMOD
8	recta	recta	I-NP	NN	O	9	NMOD
9	strain	strain	I-NP	NN	O	6	PMOD
10	372	372	I-NP	CD	O	9	NMOD
11	was	be	B-VP	VBD	O	0	ROOT
12	used	use	I-VP	VBN	O	11	VC
13	for	for	B-PP	IN	O	12	VMOD
14	indirect	indirect	B-NP	JJ	O	16	NMOD
15	immunofluorescence	immunofluorescence	I-NP	NN	O	16	NMOD
16	localization	localization	I-NP	NN	O	13	PMOD
17	of	of	B-PP	IN	O	16	NMOD
18	W.	W.	B-NP	NNP	O	19	NMOD
19	recta	recta	I-NP	NN	O	17	PMOD
20	in	in	B-PP	IN	O	16	NMOD
21	dental	dental	B-NP	JJ	O	22	NMOD
22	plaque	plaque	I-NP	NN	O	20	PMOD
23	from	from	B-PP	IN	O	22	NMOD
24	untreated	untreated	B-NP	JJ	O	27	NMOD
25	and	and	I-NP	CC	O	27	NMOD
26	treated	treat	I-NP	VBN	O	27	NMOD
27	patients	patient	I-NP	NNS	O	23	PMOD
28	.	.	O	.	O	11	P

1	Supragingival	Supragingival	B-NP	JJ	O	2	NMOD
2	plaque	plaque	I-NP	NN	O	3	SUB
3	was	be	B-VP	VBD	O	0	ROOT
4	collected	collect	I-VP	VBN	O	3	VC
5	from	from	B-PP	IN	O	4	VMOD
6	15	15	B-NP	CD	O	9	NMOD
7	periodontally	periodontally	I-NP	RB	O	8	AMOD
8	healthy	healthy	I-NP	JJ	O	9	NMOD
9	individuals	individual	I-NP	NNS	O	5	PMOD
10	(	(	O	(	O	12	DEP
11	H	H	B-NP	NN	O	12	DEP
12	)	)	O	)	O	9	NMOD
13	,	,	O	,	O	3	P
14	10	10	B-NP	CD	O	15	NMOD
15	adults	adult	I-NP	NNS	O	31	NMOD
16	with	with	B-PP	IN	O	15	NMOD
17	mild	mild	B-NP	JJ	O	18	NMOD
18	gingivitis	gingivitis	I-NP	NN	O	16	PMOD
19	(	(	O	(	O	21	DEP
20	G1	G1	B-NP	NN	O	21	DEP
21	)	)	O	)	O	18	NMOD
22	,	,	O	,	O	31	P
23	8	8	B-NP	CD	O	31	NMOD
24	with	with	B-PP	IN	O	23	NMOD
25	severe	severe	B-NP	JJ	O	26	NMOD
26	gingivitis	gingivitis	I-NP	NN	O	24	PMOD
27	(	(	O	(	O	29	DEP
28	G2	G2	B-NP	NN	O	29	DEP
29	)	)	O	)	O	26	NMOD
30	and	and	O	CC	O	31	NMOD
31	15	15	B-NP	CD	O	3	PRD
32	with	with	B-PP	IN	O	31	NMOD
33	periodontitis	periodontitis	B-NP	NN	O	32	PMOD
34	(	(	O	(	O	36	DEP
35	AP	AP	B-NP	NN	O	36	DEP
36	)	)	O	)	O	33	NMOD
37	.	.	O	.	O	3	P

1	Subgingival	Subgingival	B-NP	JJ	O	2	NMOD
2	samples	sample	I-NP	NNS	O	12	SUB
3	from	from	B-PP	IN	O	2	NMOD
4	23	23	B-NP	CD	B-DNA	6	NMOD
5	diseased	disease	I-NP	VBN	I-DNA	6	NMOD
6	sites	site	I-NP	NNS	I-DNA	3	PMOD
7	(	(	O	(	O	11	DEP
8	G2	G2	B-NP	NN	O	10	NMOD
9	and	and	O	CC	O	10	NMOD
10	AP	AP	B-NP	NN	O	11	DEP
11	)	)	O	)	O	6	NMOD
12	were	be	B-VP	VBD	O	0	ROOT
13	examined	examine	I-VP	VBN	O	12	VC
14	as	as	B-ADVP	RB	O	13	VMOD
15	well	well	I-ADVP	RB	O	14	AMOD
16	.	.	O	.	O	12	P

1	There	There	B-NP	EX	O	2	SUB
2	was	be	B-VP	VBD	O	0	ROOT
3	a	a	B-NP	DT	O	5	NMOD
4	significant	significant	I-NP	JJ	O	5	NMOD
5	difference	difference	I-NP	NN	O	2	PRD
6	(	(	O	(	O	10	DEP
7	p	p	B-NP	NN	O	10	DEP
8	=	=	B-VP	SYM	O	7	NMOD
9	0.000	0.000	B-NP	CD	O	8	AMOD
10	)	)	O	)	O	5	NMOD
11	between	between	B-PP	IN	O	5	NMOD
12	the	the	B-NP	DT	O	13	NMOD
13	proportions	proportion	I-NP	NNS	O	11	PMOD
14	of	of	B-PP	IN	O	13	NMOD
15	W.	W.	B-NP	NNP	O	16	NMOD
16	recta	recta	I-NP	NN	O	14	PMOD
17	in	in	B-PP	IN	O	13	NMOD
18	subgingival	subgingival	B-NP	JJ	O	24	NMOD
19	(	(	O	(	O	22	DEP
20	4.4	4.4	B-NP	CD	O	21	NMOD
21	%	%	I-NP	NN	O	22	DEP
22	)	)	O	)	O	18	NMOD
23	vs.	vs.	B-PP	FW	O	24	NMOD
24	supragingival	supragingival	B-ADJP	JJ	O	30	NMOD
25	(	(	O	(	O	28	DEP
26	0.3	0.3	B-NP	CD	O	27	NMOD
27	%	%	I-NP	NN	O	28	DEP
28	)	)	O	)	O	24	AMOD
29	plaque	plaque	B-NP	NN	O	30	NMOD
30	samples	sample	I-NP	NNS	O	17	PMOD
31	from	from	B-PP	IN	O	30	NMOD
32	AP	AP	B-NP	NN	B-protein	31	PMOD
33	.	.	O	.	O	2	P

1	A	A	B-NP	DT	O	3	NMOD
2	significant	significant	I-NP	JJ	O	3	NMOD
3	difference	difference	I-NP	NN	O	13	SUB
4	(	(	O	(	O	8	DEP
5	p	p	B-NP	NN	O	8	DEP
6	=	=	B-VP	SYM	O	5	NMOD
7	0.000	0.000	B-NP	CD	O	6	AMOD
8	)	)	O	)	O	3	NMOD
9	in	in	B-PP	IN	O	3	NMOD
10	W.	W.	B-NP	NNP	O	12	NMOD
11	recta	recta	I-NP	NN	O	12	NMOD
12	proportions	proportion	I-NP	NNS	O	9	PMOD
13	was	be	B-VP	VBD	O	0	ROOT
14	also	also	I-VP	RB	O	13	VMOD
15	detected	detect	I-VP	VBN	O	13	VC
16	between	between	B-PP	IN	O	15	VMOD
17	subgingival	subgingival	B-NP	JJ	O	19	NMOD
18	plaque	plaque	I-NP	NN	O	19	NMOD
19	samples	sample	I-NP	NNS	O	16	PMOD
20	of	of	B-PP	IN	O	19	NMOD
21	AP	AP	B-NP	NN	O	27	NMOD
22	(	(	O	(	O	25	DEP
23	4.4	4.4	B-NP	CD	O	24	NMOD
24	%	%	I-NP	NN	O	25	DEP
25	)	)	O	)	O	21	NMOD
26	vs.	vs.	B-NP	FW	O	27	NMOD
27	G2	G2	I-NP	NN	O	20	PMOD
28	(	(	O	(	O	31	DEP
29	1.2	1.2	B-NP	CD	O	30	NMOD
30	%	%	I-NP	NN	O	31	DEP
31	)	)	O	)	O	27	NMOD
32	.	.	O	.	O	13	P

1	No	No	B-NP	DT	O	3	NMOD
2	significant	significant	I-NP	JJ	O	3	NMOD
3	difference	difference	I-NP	NN	O	11	SUB
4	in	in	B-PP	IN	O	3	NMOD
5	the	the	B-NP	DT	O	7	NMOD
6	mean	mean	I-NP	JJ	O	7	NMOD
7	%	%	I-NP	NN	O	4	PMOD
8	of	of	B-PP	IN	O	7	NMOD
9	W.	W.	B-NP	NNP	O	10	NMOD
10	recta	recta	I-NP	NN	O	8	PMOD
11	was	be	B-VP	VBD	O	0	ROOT
12	found	find	I-VP	VBN	O	11	VC
13	between	between	B-PP	IN	O	12	VMOD
14	supragingival	supragingival	B-NP	JJ	O	15	NMOD
15	plaque	plaque	I-NP	NN	O	13	PMOD
16	of	of	B-PP	IN	O	15	NMOD
17	AP	AP	B-NP	NN	O	23	NMOD
18	(	(	O	(	O	21	DEP
19	0.3	0.3	B-NP	CD	O	20	NMOD
20	%	%	I-NP	NN	O	21	DEP
21	)	)	O	)	O	17	NMOD
22	and	and	O	CC	O	23	NMOD
23	G2	G2	B-NP	NN	O	16	PMOD
24	(	(	O	(	O	27	DEP
25	0	0	B-NP	CD	O	26	NMOD
26	%	%	I-NP	NN	O	27	DEP
27	)	)	O	)	O	15	NMOD
28	,	,	O	,	O	30	P
29	and	and	O	CC	O	30	NMOD
30	samples	sample	B-NP	NNS	O	11	VMOD
31	of	of	B-PP	IN	O	30	NMOD
32	G1	G1	B-NP	NN	O	38	NMOD
33	(	(	O	(	O	36	DEP
34	0.01	0.01	B-NP	CD	O	35	NMOD
35	%	%	I-NP	NN	O	36	DEP
36	)	)	O	)	O	32	NMOD
37	and	and	O	CC	O	38	NMOD
38	H	H	B-NP	NN	O	31	PMOD
39	(	(	O	(	O	42	DEP
40	0.1	0.1	B-NP	CD	O	41	NMOD
41	%	%	I-NP	NN	O	42	DEP
42	)	)	O	)	O	38	NMOD
43	.	.	O	.	O	11	P

1	In	In	B-PP	IN	O	16	VMOD
2	a	a	B-NP	DT	O	4	NMOD
3	separate	separate	I-NP	JJ	O	4	NMOD
4	study	study	I-NP	NN	O	1	PMOD
5	,	,	O	,	O	16	P
6	85	85	B-NP	CD	O	7	NMOD
7	adults	adult	I-NP	NNS	O	16	SUB
8	previously	previously	B-VP	RB	O	9	VMOD
9	treated	treat	I-VP	VBN	O	7	NMOD
10	for	for	B-PP	IN	O	9	VMOD
11	moderate	moderate	B-ADJP	JJ	O	10	PMOD
12	to	to	B-PP	TO	O	11	AMOD
13	severe	severe	B-NP	JJ	O	14	AMOD
14	adult	adult	I-NP	JJ	O	15	NMOD
15	periodontitis	periodontitis	I-NP	NN	O	12	PMOD
16	were	be	B-VP	VBD	O	0	ROOT
17	monitored	monitor	I-VP	VBN	O	16	VC
18	over	over	B-PP	IN	O	17	VMOD
19	a	a	B-NP	DT	O	21	NMOD
20	12-month	12-month	I-NP	JJ	O	21	NMOD
21	period	period	I-NP	NN	O	18	PMOD
22	for	for	B-PP	IN	O	21	NMOD
23	evidence	evidence	B-NP	NN	O	22	PMOD
24	of	of	B-PP	IN	O	23	NMOD
25	disease	disease	B-NP	NN	O	26	NMOD
26	recurrence	recurrence	I-NP	NN	O	24	PMOD
27	.	.	O	.	O	16	P

1	Recurrent	Recurrent	B-NP	JJ	O	2	NMOD
2	disease	disease	I-NP	NN	O	3	SUB
3	was	be	B-VP	VBD	O	0	ROOT
4	detected	detect	I-VP	VBN	O	3	VC
5	at	at	B-PP	IN	O	4	VMOD
6	32	32	B-NP	CD	B-DNA	7	NMOD
7	sites	site	I-NP	NNS	I-DNA	5	PMOD
8	in	in	B-PP	IN	O	7	NMOD
9	18	18	B-NP	CD	O	10	NMOD
10	subjects	subject	I-NP	NNS	O	8	PMOD
11	.	.	O	.	O	3	P

1	Of	Of	B-PP	IN	O	9	VMOD
2	these	these	B-NP	DT	O	1	PMOD
3	,	,	O	,	O	9	P
4	20	20	B-NP	CD	O	5	NMOD
5	sites	site	I-NP	NNS	O	9	SUB
6	in	in	B-PP	IN	O	5	NMOD
7	13	13	B-NP	CD	O	8	NMOD
8	subjects	subject	I-NP	NNS	O	6	PMOD
9	were	be	B-VP	VBD	O	0	ROOT
10	positive	positive	B-ADJP	JJ	O	9	PRD
11	for	for	B-PP	IN	O	10	AMOD
12	W.	W.	B-NP	NNP	O	13	NMOD
13	recta	recta	I-NP	NN	O	11	PMOD
14	.	.	O	.	O	9	P

1	With	With	B-PP	IN	O	17	VMOD
2	subjects	subject	B-NP	NNS	O	1	PMOD
3	as	as	B-PP	IN	O	2	NMOD
4	the	the	B-NP	DT	O	6	NMOD
5	experimental	experimental	I-NP	JJ	O	6	NMOD
6	unit	unit	I-NP	NN	O	10	NMOD
7	,	,	O	,	O	10	P
8	a	a	B-NP	DT	O	10	NMOD
9	significant	significant	I-NP	JJ	O	10	NMOD
10	increase	increase	I-NP	NN	O	3	PMOD
11	in	in	B-PP	IN	O	10	NMOD
12	the	the	B-NP	DT	O	13	NMOD
13	proportions	proportion	I-NP	NNS	O	11	PMOD
14	of	of	B-PP	IN	O	13	NMOD
15	W.	W.	B-NP	NNP	O	16	NMOD
16	recta	recta	I-NP	NN	O	14	PMOD
17	was	be	B-VP	VBD	O	0	ROOT
18	found	find	I-VP	VBN	O	17	VC
19	at	at	B-PP	IN	O	18	VMOD
20	sites	site	B-NP	NNS	O	19	PMOD
21	with	with	B-PP	IN	O	20	NMOD
22	recurrent	recurrent	B-NP	JJ	O	23	NMOD
23	disease	disease	I-NP	NN	O	21	PMOD
24	(	(	O	(	O	27	DEP
25	3.12	3.12	B-NP	CD	O	26	NMOD
26	%	%	I-NP	NN	O	27	DEP
27	)	)	O	)	O	23	NMOD
28	as	as	B-SBAR	IN	O	17	VMOD
29	compared	compare	B-VP	VBN	O	28	SBAR
30	to	to	B-PP	TO	O	29	VMOD
31	stable	stable	B-NP	JJ	O	33	AMOD
32	,	,	I-NP	,	O	33	P
33	paired	paired	I-NP	JJ	B-DNA	35	NMOD
34	control	control	I-NP	NN	I-DNA	35	NMOD
35	sites	site	I-NP	NNS	I-DNA	30	PMOD
36	(	(	O	(	O	39	DEP
37	0.24	0.24	B-NP	CD	O	38	NMOD
38	%	%	I-NP	NN	O	39	DEP
39	)	)	O	)	O	35	NMOD
40	,	,	O	,	O	28	P
41	but	but	O	CC	O	28	DEP
42	only	only	O	RB	O	28	DEP
43	when	when	B-ADVP	WRB	O	28	DEP
44	sites	site	B-NP	NNS	O	52	SUB
45	with	with	B-PP	IN	O	44	NMOD
46	breakdown	breakdown	B-NP	NN	O	45	PMOD
47	and	and	O	CC	O	44	NMOD
48	positive	positive	B-ADJP	JJ	O	44	NMOD
49	for	for	B-PP	IN	O	48	AMOD
50	W.	W.	B-NP	NNP	O	51	NMOD
51	recta	recta	I-NP	NN	O	49	PMOD
52	were	be	B-VP	VBD	O	43	SBAR
53	compared	compare	I-VP	VBN	O	52	VC
54	with	with	B-PP	IN	O	53	VMOD
55	their	their	B-NP	PRP$	O	56	NMOD
56	controls	control	I-NP	NNS	O	54	PMOD
57	.	.	O	.	O	17	P

1	These	These	B-NP	DT	O	2	NMOD
2	results	result	I-NP	NNS	O	3	SUB
3	indicate	indicate	B-VP	VBP	O	0	ROOT
4	that	that	B-SBAR	IN	O	3	VMOD
5	W.	W.	B-NP	NNP	O	6	NMOD
6	recta	recta	I-NP	NN	O	7	SUB
7	is	be	B-VP	VBZ	O	4	SBAR
8	associated	associate	I-VP	VBN	O	7	VC
9	with	with	B-PP	IN	O	8	VMOD
10	some	some	B-NP	DT	O	9	PMOD
11	,	,	O	,	O	10	P
12	but	but	O	CC	O	11	PMOD
13	not	not	B-NP	RB	O	15	NMOD
14	all	all	I-NP	DT	O	15	NMOD
15	sites	site	I-NP	NNS	O	12	PRD
16	with	with	B-PP	IN	O	15	NMOD
17	advanced	advance	B-NP	VBN	O	19	NMOD
18	adult	adult	I-NP	JJ	O	19	NMOD
19	periodontitis	periodontitis	I-NP	NN	O	16	PMOD
20	.	.	O	.	O	12	P

1	The	The	B-NP	DT	O	2	NMOD
2	association	association	I-NP	NN	O	8	SUB
3	of	of	B-PP	IN	O	2	NMOD
4	W.	W.	B-NP	NNP	O	5	NMOD
5	recta	recta	I-NP	NN	O	3	PMOD
6	with	with	B-PP	IN	O	2	NMOD
7	gingivitis	gingivitis	B-NP	NN	O	6	PMOD
8	was	be	B-VP	VBD	O	0	ROOT
9	not	not	O	RB	O	8	VMOD
10	statistically	statistically	B-ADJP	RB	O	8	VMOD
11	significant	significant	I-ADJP	JJ	O	8	PRD
12	.	.	O	.	O	8	P

